Search Results
Results found for "GPCR Drug Discovery"
- Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..
October 2022 Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Autoimmune Diseases "The chemokine receptor CXCR3 is a seven-transmembrane G-protein-coupled receptor (GPCR high-throughput screening hit, we describe the iterative optimization of a chemical series culminating in the discovery Read more at the source #DrGPCR #GPCR #IndustryNews
- Effect Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells
Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, February 27 to March 5, 2023
Function and structure of bradykinin receptor 2 for drug discovery. discovery platform Antiverse identifies therapeutic antibodies targeting GPCRs CEO Andrew Hopkins on Exscientias AI-Driven Approach to Modern Drug Discovery Arcoscreen will present in the start-up village Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Computational drug design postdoc at the Department of Drug Design and Pharmacology.
- Lipid Modulation of a Class B GPCR: Elucidating the Modulatory Role of PI(4,5)P 2 Lipids
lipids have been shown to stabilize an active conformation of class A G-protein coupled receptors (GPCRs ) through a conserved binding site, not present in class B GPCRs. For class B GPCRs, previous molecular dynamics (MD) simulation studies have shown PI(4,5)P2 interacting conformation of GCGR through a binding site conserved across class B GPCRs but absent in class A GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews
- Dimerization of β2-adrenergic receptor is responsible for the constitutive activity subjected to inv
Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE
- InterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...
Ingelheim take first steps towards collaborating to unlock orphan targets leveraging InterAx AI driven discovery accelerate and improve the prediction of first-in-class small molecule agonists for a challenging orphan GPCR for a highly relevant therapeutic need. 💊 InterAx Biotech AG discovery platform was already successfully #ai #biotech #systemsbiology #drugdiscovery #gpcr #deeptech #orphandrugs #pharma #partnerships #AI4drugdiscovery " Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, March 27 to April 4, 2023
GPCR Binders, Drugs, and more Predicting allosteric sites using fast conformational sampling as guided Methods & Updates in GPCR Research Discovery and design of G protein-coupled receptor targeting antibodies Investigating the potential of GalR2 as a drug target for neuropathic pain. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. GPCR Ecosystem
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
Recently, several GPCRs have been found to play important roles in the cochlea. Frizzleds and Lgrs are dominant GPCRs that regulate stem cell self-renew abilities. And A1, A2A, and CB2 activation by agonists has protective functions on noise- or drug-induced hearing Here, we review the key findings of GPCR in the cochlea and discuss the role of GPCR in the cochlea, Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter
- Dr. Simone Promel
GPCR Virtual Cafe? Join us for another virtual cafe talk to hear about the amazing work that Dr. Simone Promel / Promel Lab is doing on adhesion #GPCRs. Register here (free): https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #podcast
- Production of human A2AAR in lipid nanodiscs for 19F-NMR and single-molecule fluorescence...
describe production of the human A2A adenosine receptor (A2AAR), a class A G protein-coupled receptor (GPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
However, the drug development of CX3CR1 is hampered partially by the lack of structural information. A much smaller conformational change of helix VI upon activation than previously solved class A GPCR-Gi Thus, our data deepen the understanding of cholesterol modulation in GPCR (G protein-coupled receptor Read more at the source #DrGPCR #GPCR #IndustryNews
- 8th RSC / SCI symposium on GPCRs in Medicinal Chemistry. October 5-7, 2022, Verona, Italy
August 2022 "GPCRs in Medicinal Chemistry Event 8th RSC / SCI symposium on GPCRs in Medicinal Chemistry 6th September 30th September – online registration (card payments)" Read more at the source #DrGPCR #GPCR
- Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin ...
We previously demonstrated that the G protein-coupled receptor (GPCR) arginine vasopressin receptor type1A AVPR1A is part of a family of GPCR's including arginine vasopressin receptor type 2 (AVPR2). Read more at the source #DrGPCR #GPCR #IndustryNews
- Functional Characterization of the Venus Flytrap Domain of the Human TAS1R2 Sweet Taste Receptor
sweet taste receptor is a heterodimeric receptor composed of two distinct G-protein-coupled receptors (GPCRs The TAS1R2 and TAS1R3 subunits are members of a small family of class C GPCRs whose members share the Read more at the source #DrGPCR #GPCR #IndustryNews
- Regulators of G-protein signaling: essential players in GPCR signaling
components of the intracellular signaling pathways that mediate the effects of G protein-coupled receptors (GPCRs Upon activation, GPCRs have conformational changes that allow the coupling and subsequent activation Role of RGS proteins in regulating GPCR signaling: Recent studies have revealed that the interaction The interaction between RGS proteins and GPCRs is highly specific and tightly regulated; mutations in and amplitude of GPCR signaling.
- Structure of the vasopressin hormone-V2 receptor-β-arrestin1 ternary complex
October 2022 "Arrestins interact with G protein-coupled receptors (GPCRs) to stop G protein activation Recent structural studies shed light on the molecular mechanisms involved in GPCR-arrestin coupling, but whether this process is conserved among GPCRs is poorly understood. It reveals an atypical position of β-arrestin1 compared to previously described GPCR-arrestin assemblies Read more at the source #DrGPCR #GPCR #IndustryNews
- Arginine 125 Is an Essential Residue for the Function of MRAP2
helps in elucidating the metabolic pathways involved in metabolic dysfunction and in developing new drugs Read more at the source #DrGPCR #GPCR #IndustryNews
- Adenosine receptor signalling in Alzheimer's disease
Emerging evidence suggests adenosine G protein-coupled receptors (GPCRs) are promising therapeutic targets into some novel strategies, including allosterism and the targeting of oligomers, which may increase drug discovery success and enhance the therapeutic response." Read more at the source #DrGPCR #GPCR #IndustryNews
- Adenosine receptor signalling in Alzheimer's disease
Emerging evidence suggests adenosine G protein-coupled receptors (GPCRs) are promising therapeutic targets into some novel strategies, including allosterism and the targeting of oligomers, which may increase drug discovery success and enhance the therapeutic response." Read more at the source #DrGPCR #GPCR #IndustryNews
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
October 2022 "Recently determined structures of class C G protein-coupled receptors (GPCRs) revealed the location of allosteric binding sites and opened new opportunities for the discovery of novel modulators treatment of psychiatric and neurodegenerative diseases, and several allosteric modulators of this GPCR in complex with allosteric modulators can accelerate lead discovery." Read more at the source #DrGPCR #GPCR #IndustryNews
- 🎧Episode 85 of the Dr. GPCR podcast is here!
GPCR podcast is here! 🎧Hear Dr. GPCR Ecosystem membership or listen wherever you get your podcast for free.
- Diversification of PAR signaling through receptor crosstalk
Read more at the source #DrGPCR #GPCR #IndustryNews
- Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
Therefore, mGluR2 and mGluR3 have been considered as potential drug targets for the treatment of many Alzheimer's disease, Huntington's disease, Parkinson's diseases, schizophrenia and depression as well as drug We then highlight the evidence supporting the use of various drugs including orthosteric and allosteric Read more at the source #DrGPCR #GPCR #IndustryNews
- New structural perspectives in G protein-coupled receptor-mediated Src family kinase activation
Sandra Berndt talk about new structural perspectives in GPCR-mediated Src family kinase activation. Register here (FREE) https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe #drgpcr #gpcr #virtualcafe
- GRK2 in cardiovascular disease and its potential as a therapeutic target
G protein-coupled receptors (GPCRs) are critical myocardial signal transducers which regulate cardiac Additionally, GPCR dysregulation underlies multiple models of cardiac pathology, and most pharmacological A recent focus on GPCR intracellular-regulating proteins such as GPCR kinases (GRKs) has uncovered GRK2 These data support the premise that GRK2 should be at the forefront of a novel investigative drug search Read more at the source #DrGPCR #GPCR #IndustryNews
- GPR110, a receptor for synaptamide, expressed in osteoclasts negatively regulates osteoclastogenesis
Although some G-protein coupled receptors (GPCRs) were reported to play roles in osteoblast function, GPR110 belongs to adhesion GPCR and was the functional receptor of N-docosahexaenoyl ethanolamine (also Our study suggested that ligands of GPR110, such as synaptamide, might be a useful drug for osteoporotic Read more at the source #DrGPCR #GPCR #IndustryNews
- G protein-coupled receptor 21 in macrophages: An in vitro study
orphan and constitutively active receptor belonging to the superfamily of G-Protein Coupled Receptors (GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Drug discovery often assumes receptor inhibition follows simple rules—agonist binds, antagonist blocks That paper quantified how one drug could block another’s access to a receptor—a framework that Heinz The Quick Glance: pA₂ as Shortcut Sometimes, discovery projects don’t have the luxury of full curve analyses Built for pharmacologists refining tools, discovery teams solving bottlenecks, and leaders seeking credible GPCR innovation is accelerating—those who act now will define tomorrow’s breakthroughs.
- Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi...
scoring protective hits included the complement C3a receptor (C3aR), a G-protein coupled receptor (GPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
Don’t miss out on insightful resources like ' Applying Pharmacology to Drug Discovery ' and ' Advanced discovery strategies. agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models Discovery Discovery GPCR Events, Meetings, and Webinars September 5 - 6, 2024 | 4th Transatlantic ECI GPCR Symposium September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays in drug discovery October 2024





